New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
DiaMedica Therapeutics Inc.
DMAC
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

182M

Biotechnology

Next Earning date - 11 Nov 2024

182M

Biotechnology

Next Earning date - 11 Nov 2024

4.25USD
Shape-0.17 ( -3.85%)
favorite-chart

Relative Strenght

28
favorite-chart

Volume Buzz

-67%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

14%

Quote Panel

Shape
Updated October 12, 2024
1W -2.75 % 1M -5.56 % 3M 18.72 % 1Y 107.32 %

Key Metrics

Shape
  • Market Cap

    181.68M


  • Shares Outstanding

    42.75M


  • Share in Float

    24.01M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    4.25


  • Average Volume

    54553


  • Beta

    1.478


  • Range

    2.05-4.95


  • Industry

    Biotechnology


  • Website

    https://www.diamedica.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

6.04x

P/S Ratio

3.11x

P/B Ratio

0.0

Debt/Equity

-64.5%

Net Margin

$-0.5

EPS

How DMAC compares to sector?

P/E Ratio

Relative Strength

Shape

DMAC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$0.76

Shape-485%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2024-10-07

Now: Buy

Oppenheimer

upgrade

Previous: Not converted

2023-06-22

Now: Outperform

Oppenheimer

upgrade

Previous: Not converted

2023-06-22

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.12
vs -0.18

Q4.22

arrow
arrow

N/A

-0.14
vs -0.10

Q1.23

arrow
arrow

N/A

-0.20
vs -0.13

Q2.23

arrow
arrow

N/A

-0.16
vs -0.13

Q3.23

arrow
arrow

N/A

-0.12
vs -0.12

Q4.23

arrow
arrow

N/A

-0.14
vs -0.14

Q1.24

arrow
arrow

N/A

-0.14
vs -0.20

Q2.24

arrow
arrow

N/A

-0.13
vs -0.16

Q3.24

arrow
arrow

N/A

-0.15
vs -0.12

Q4.24

arrow
arrow

N/A

-0.17
vs -0.14

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

13K  vs NA

Q3.22

arrow
arrow

NA

76K  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

-100%

NA  vs 13K

Q3.23

arrow
arrow

-100%

NA  vs 76K

Q4.23

arrow
arrow

NA

30.8M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-9%

-0.09
vs -0.09

Q4.22

arrow
arrow

-12%

-0.12
vs -0.09

Q1.23

arrow
arrow

-20%

-0.20
vs -0.12

Q2.23

arrow
arrow

-7%

-0.07
vs -0.20

Q3.23

arrow
arrow

-8%

-0.08
vs -0.07

Q4.23

arrow
arrow

-10%

-0.10
vs -0.08

Q1.24

arrow
arrow

-11%

-0.11
vs -0.10

Q2.24

arrow
arrow

-10%

-0.10
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

25

25
vs 27

-7%

Q4.22

arrow
arrow

31

31
vs 25

24%

Q1.23

arrow
arrow

26

26
vs 31

-16%

Q2.23

arrow
arrow

33

33
vs 26

27%

Q3.23

arrow
arrow

39

39
vs 33

18%

Q4.23

arrow
arrow

40

40
vs 39

3%

Q1.24

arrow
arrow

34

34
vs 40

-15%

Q2.24

arrow
arrow

34

34
vs 34

NA

Earnings Growth

Latest News